MAPT and Alzheimer disease: While the initiating factors vary with the specific tauopathy and often remain unknown, the transition of Tau into insoluble structures follows a common path that was originally identified for AD: Tau monomers first become phosphorylated and then hyperphosphorylated as they form oligomers that organize into paired helical filaments (PHFs), which transform into NFTs [20].